For procurement professionals in the pharmaceutical and fine chemical sectors, a thorough understanding of the materials they source is vital. Riluzole, with CAS number 1744-22-5, is one such compound that warrants close examination due to its significance as a pharmaceutical intermediate. This article aims to provide procurement managers with a comprehensive overview of Riluzole, its properties, applications, and the strategic considerations when looking to buy this compound from China.

Riluzole (CAS 1744-22-5) is typically characterized by its appearance as a light yellow powder or crystal, and it is highly valued for its purity, often exceeding 99.5%. This high degree of purity is a critical requirement for its use in pharmaceutical synthesis, where it serves as a foundational building block for more complex drug molecules. Its specific chemical structure allows it to participate in various synthetic reactions, contributing to the development of novel therapeutics, particularly those targeting neurological pathways.

When considering the acquisition of Riluzole, procurement managers are often driven by a need for both quality and cost-effectiveness. China has emerged as a leading global supplier for such intermediates. Identifying reliable 'Riluzole CAS 1744-22-5 manufacturers' and 'suppliers' in China is key to achieving competitive pricing and ensuring a consistent supply chain. It is advisable to inquire about the supplier's adherence to international quality standards and their ability to provide comprehensive documentation, such as Certificates of Analysis (COA).

The 'price for Riluzole CAS 1744-22-5' is a significant factor in procurement decisions. By sourcing directly from manufacturers in China, companies can often achieve substantial cost savings. However, it is essential to balance cost with quality. A lower price should not come at the expense of purity or reliability. Therefore, a thorough vetting process of potential suppliers is indispensable. This might involve requesting samples, reviewing quality certifications, and understanding their production capacity.

In essence, Riluzole CAS 1744-22-5 represents a crucial intermediate in the pharmaceutical supply chain. For procurement professionals, understanding its specifications, applications, and the strategic advantages of sourcing from China – including competitive pricing and a wide network of manufacturers – empowers informed decision-making. By forging strong relationships with trusted suppliers, companies can ensure a steady and high-quality supply of this vital compound for their ongoing projects and manufacturing needs.